Podcasts about memory disorders program

Torn N 2 with Gregory T. Roberts and Melvin Burns II, featuring our special guest, Dr. Kevin Foley regarding Alzheimer's and Dementia. Dr. Foley is board certified in Internal Medicine, subspecialty Geriatric Medicine, and serves as Medical Director of Trinity Health Hauenstein Neuroscience Center Alzheimer's Disease and Memory Disorders Program in Grand Rapids and as Associate Professor and Director of Geriatrics, Michigan State University College of Human Medicine. 

The key to understanding Alzheimer's disease could be in our genes. While the cause of Alzheimer's is still unknown, mounting research shows that carrying multiple copies of certain genes — like genetic variant ApoE4 — can significantly increase the likelihood of developing Alzheimer's. By studying genetics and gene therapy, scientists are learning more about how genes play a role in Alzheimer's disease and what can be done for prevention. Barrow Neurological Institute's neurologist, author, and Alzheimer's expert Dr. Marwan Sabbagh joins Being Patient to discuss how scientists are seeking to prevent Alzheimer's through genetic research. Sabbagh, a board-certified behavioral neurologist at Barrow's Alzheimer's and Memory Disorders Program and a professor at the institute's department of neurology, has served as the lead investigator on several prominent national Alzheimer's prevention and treatment clinical trials. In this talk, he'll speak about how genetic research, like that on the ApoE4 gene, can help us learn more about Alzheimer's and how it can be prevented. This Live Talk is sponsored by Alzheon.

The key to understanding Alzheimer's disease could be in our genes. While the cause of Alzheimer's is still unknown, mounting research shows that carrying multiple copies of certain genes — like genetic variant ApoE4 — can significantly increase the likelihood of developing Alzheimer's. By studying genetics and gene therapy, scientists are learning more about how genes play a role in Alzheimer's disease and what can be done for prevention. Barrow Neurological Institute's neurologist, author, and Alzheimer's expert Dr. Marwan Sabbagh joins Being Patient to discuss how scientists are seeking to prevent Alzheimer's through genetic research. Sabbagh, a board-certified behavioral neurologist at Barrow's Alzheimer's and Memory Disorders Program and a professor at the institute's department of neurology, has served as the lead investigator on several prominent national Alzheimer's prevention and treatment clinical trials. In this talk, he'll speak about how genetic research, like that on the ApoE4 gene, can help us learn more about Alzheimer's and how it can be prevented. This Live Talk is sponsored by Alzheon. Watch now to learn more about the genetics of Alzheimer's disease. If you loved watching this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/ Follow Being Patient: Twitter:   / being_patient_   Instagram:   / beingpatientvoices   Facebook:   / beingpatientalzheimers   LinkedIn:   / being-patient   Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia.

atching and accurately identifying a neurodegenerative disease like Alzheimer's or another form of dementia early can make all the difference in the world to a patient and their loved ones: An early diagnosis means more time to plan for the future, join a clinical trial testing cutting-edge disease-modifying treatments, making lifestyle changes to slow symptoms, or spending more time with loved ones. On the other hand, a misdiagnosis could mean that patients receive the wrong medications, causing harm — and unfortunately misdiagnoses are all too common when it comes to dementia. Why is this the case, and what can patients do about it? Neurologist, author, and Alzheimer's expert Dr. Marwan Sabbagh joins Being Patient Live Talks to discuss why dementias are so difficult to diagnose. Sabbagh, a board-certified behavioral neurologist at Barrow Neurological Institute's Alzheimer's and Memory Disorders Program and a professor at the institute's Department of Neurology, has served as the lead investigator on a number of prominent national Alzheimer's prevention and treatment clinical trials. In this talk, he'll speak to the factors that make dementia so difficult to diagnose accurately for experts and clinicians — as well as what patients and their families can do to advocate for an accurate diagnosis and a faster response to brain health concerns. Watch the full video to learn more about what caregivers and people living with dementia should know about diagnosis. If you loved watching this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/ Follow Being Patient: Twitter:   / being_patient_   Instagram:   / beingpatientvoices   Facebook:   / beingpatientalzheimers   LinkedIn:   / being-patient   Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category...#Alzheimers #Dementia #BrainTalk #Diagnosis

Eisai Co., Ltd. and Biogen Inc. announced on January 6th that under the Accelerated Approval Pathway the U.S. Food and Drug Administration (FDA) has approved lecanemab-irmb, which has the brand name in the United States of LEQEMBITM, for the treatment of Alzheimer's disease.  The approval is based on Phase 2 data that demonstrated that LEQEMBI reduced the accumulation of Aβ plaque in the brain, a defining feature of Alzheimer's disease.  Newt's guest is Dr. Marwan Sabbagh, MD.  He is a behavioral neurologist in the Alzheimer's and Memory Disorders Program and a professor in the Department of Neurology at Barrow Neurological Institute and was one of the leading doctors of the study.See omnystudio.com/listener for privacy information.

In Episode 11 of Alz In The Fam, Allan and Poli detail the final steps of receiving our Mom’s official diagnosis of Alzheimer’s disease. The steps we took at this stage, starting with an appointment with our Mom’s primary care physician, all culminated in finding great treatment and resources for our Mom.When we first went to Mom’s primary care physician, Mom took the Mini Mental Status Exam – a standard exam with a series of questions that help health professionals evaluate the memory issues in their patients. Mom failed this exam, but the assistant who administered the test thought Mom was fine. Her physician decided to refer us to a neurologist. Neurologists, however, are incredibly busy. Getting an appointment took a lot of time, but Poli was directed to the Georgetown University’s Memory Disorders Program and was able to get Mom in for an appointment sooner than most.Getting involved at the GU Memory Disorders Program proved to be the best move we could have made. Here, we enrolled Mom in an Alzheimer’s study and started being seen by a neurologist every month. Joining a study was the best experience for our family; it provided us with tons of resources and incredible staff that we can still rely on. Our start at GU Memory Disorders Program gave Mom her first official diagnosis of mild Alzheimer’s disease, too. This was a huge milestone in our journey. GU has provided us with crucial care and a strong community, both of which have made a huge impact in our Mom’s life and our entire families’ lives. Finally, we just want to note that no experience with Alzheimer’s is linear. Some days are much harder than others, and some days your loved one may seem like her old self again. Being a caregiver is difficult and unpredictable; having a support system and community to rely on is crucial as caregivers. We hope that those in a similar position can find care that they feel confident about and a community that they can connect with. If you enjoy the podcast, would you please consider leaving a short review on Apple Podcast/iTunes? 

In Episode 10 of Alz In The Fam, Brigid Reynolds, Neurology Provider at Georgetown University’s Memory Disorders Program joins the Fair siblings for another great episode. In this conversation, Brigid shares exciting studies and research happening in the memory disorder field. When we first met Brigid, she recommended that our Mom joined an Alzheimer’s trial drug study, and it was an incredible experience for our whole family. The trial drug was hoping to target amyloid plaque buildup in the brains of Alzheimer’s patients. Not only did we see a positive effect in our Mom’s symptoms, but overall it was a very insightful and pleasant experience. Along with clinical trials for those with mild Alzheimer’s disease, Brigid also highlighted various studies that people who are at higher risk of developing Alzheimer’s can get involved in now, before they see any signs of the disease. One in particular that Poli, Boni and Trissi already participate in is the APT webstudy. This study uses online testing to monitor participants’ brain health over time and detect any signs of developing Alzheimer’s symptoms. Brigid also mentions exciting new research developments, like the proximity to a blood test that can detect Alzheimer’s disease in patients. Read more about that here: https://www.nytimes.com/2020/07/28/health/alzheimers-blood-test.html Other studies or research databases that Brigid recommends anyone and everyone get involved in are the AHEAD Study and the Brain Health Registry. Both are aimed at detecting Alzheimer’s in the brain before symptoms arise. We also want to emphasize how important it is for this research to include a diverse range of participants. The studies mentioned above are easily accessible online, so please help us widen the participant pool by joining yourself and sharing with others. Thank you again to Brigid Reynolds for joining us on two great episodes. Check out Brigid Reynold’s bio here: https://memory.georgetown.edu/about_us/team/Check out Georgetown University’s Memory Disorders Program here: https://memory.georgetown.edu/ If you enjoy the podcast, would you please consider leaving a short review on Apple Podcast/iTunes?

Episode 9 of Alz In The Fam features Brigid Reynolds – our Mom’s neurology provider at Georgetown University’s Memory Disorders Program. All four Fair siblings sit down with Brigid, our first ever guest, to discuss Mom’s journey with Alzheimer’s! Brigid is a research investigator conducting different clinical trials to develop new treatments for Alzheimer’s disease. She specializes in evaluating and treating patients with memory problems, like our Mom. In this episode, Brigid gives us insight into how she evaluates and treats her patients, and the types of tests she administers to diagnose and create a treatment plan. She explains the different types of memory disorders, including various types of dementia. Brigid emphasizes the importance of family members’ involvement in the process of diagnosing and treating loved ones with Alzheimer’s. She tells us why it is important that family members encourage their loved ones to seek treatment early. She discusses some current research opportunities and studies being done in the Alzheimer’s and dementia field. Check out this information on an Alzheimer’s Blood Test, as mentioned by Brigid in the episode: https://www.nytimes.com/2020/07/28/health/alzheimers-blood-test.html We are so grateful to Brigid for sitting down to speak with us. Brigid has been a blessing in our Mom’s journey with Alzheimer’s. Stay tuned next week, too, to hear more from her. Check out Brigid Reynold’s bio here: https://memory.georgetown.edu/about_us/team/Check out Georgetown University’s Memory Disorders Program here: https://memory.georgetown.edu/ If you enjoy the podcast, would you please consider leaving a short review on Apple Podcast/iTunes? 

Live Right Now - Episode 014 - Dietary Psychiatry Dietary Psychiatry: malnutrition and cognitive function After locking my keys inside the car while it was still running and Sandra rolling over one morning asking, “Who are you and why are you in my bed”; both in our early 70’s, we acknowledged our mental health is indeed fading. But seriously, there is mounting acceptance on the use of food and supplements to provide essential nutrients as part of a treatment for mental health disorders relating to depression, cognitive function, and dementia. As we age, memory blips will increase, although you needn’t put out the welcome mat. Widespread senior malnutrition in America is serious biz. According to the National Resource Center on Nutrition, Physical Activity, and Aging, 1 in 4 older Americans has poor nutrition… in America, in the 21st century. Looking back, I’m certain the quality of Mom’s late life would’ve have been richer if she’d chosen or been encouraged to eat more than a processed deli turkey sandwich on nasty white bread with Miracle Whip and a sweet pickle every day, 365 days a year. A paper napkin has more nutrition for goodness sake. Saturated fat, white flour, chemical preservatives, and sugars fertilize mental decline and starve the cells of much needed vitamin nutrition. All life’s food choices profoundly affect their mental health. The NIH reports a lack of wholesome vitamin nutrition from fresh, not canned, frozen or processed institutional food, contributes to the onset of poor mental health in people suffering from anxiety and depression, bipolar disorder, and schizophrenia. Because we’ve become somewhat disconnected from the garden since the Industrial Revolution and plugged in to “Man’s egoic genetically manipulated version of a garden”, modern seniors are woefully deprived in foods and nutrients considered “brain food”: omega-3 fatty acids from cold water fish, flax and chia seeds, walnuts, cholesterol (yes cholesterol), D-3, B-complex, especially B12. Regarding cholesterol, aka, brain food, at least a dozen reports show the risk of suicide may be substantially higher in people with low cholesterol. In a French study that tracked 6,393 men, published in the September 1996 issue of the British Medical Journal, those with low cholesterol were three times more likely than the other men to kill themselves. A link between low cholesterol and depression has turned up in other studies. Hmm? cholesterol was never really the health boogeyman the medical community made it out to be. Your brain needs cholesterol to grow new nerve cells and for these nerve cells to work properly. And when your brain is deprived of cholesterol, things don’t go so well up there. In fact, researchers at Joslin Diabetes Center say without enough cholesterol, you may even develop serious brain diseases like Alzheimer’s and Parkinson’s. Of course, "Physical exercise has the best evidence for preserving memory and mental function with aging," says R. Scott Turner, MD, PhD, director of the Memory Disorders Program at Georgetown University Medical Center In a world where we’ve been programmed to let others form our thoughts and opinions, we’ve long forgotten who calls the shots and knows what’s best, and it’s not a food corporation. We’ve departed the road of nutritional righteousness: disconnected earth’s apothecary. It’s happened so slowly we’ve not noticed how far we’ve strayed from the perfect plant-based diet or cells understand. Man cannot outsmart the mechanics of a universe he’s incapable of understanding and will never improve on Mother Earth. During this magnificent golden period of your life, give extra consideration to what foods you choose to eat.  You were gifted one strong, sacred and beautiful temple by the One Divine Mind. Embrace it with dietary self-love. Choose to focus your thoughts on remaining the clear-headed, beautiful unique being you are for as long as you can and not lock your keys in the idling car or waking up next to a stranger. https://www.webmd.com/men/features/can-your-cholesterol-be-too-low-feature#1 https://theconversation.com/why-nutritional-psychiatry-is-the-future-of-mental-health-treatment-92545?utm_medium=ampemail&utm_source=email   https://pilotonline.com/inside-business/news/columns/article_42cec91a-7158-5d52-92b8-97b46bc145ff.html?__vfz=medium%3Dsharebar   FACTORS LEADING TO NUTRITIONAL DEFICIENCY AND INSUFFICIENCY A divorce from nature-disconnected to source Start paying attention to how eating different foods makes you feel — not just in the moment, but the next day. Try eating a “clean” plant food diet for two to three weeks. Cut out all processed foods and sugar. Add fermented foods like kimchi, miso, sauerkraut, pickles, or kombucha. try going dairy-free — Some feel better when their diets are grain-free. See how you feel. Then slowly introduce foods back into your diet, one by one, and see how you feel. Studies show when people take probiotics (supplements containing the good bacteria), their anxiety levels, perception of stress, and mental outlook improve, compared with people who did not take probiotic (Lancet and Harvard.)   Vitamin DEFICIENCY / INSUFFICIENCY. FOLATE Folate is especially promising for depression-Dark leafy greens, asparagus, broccoli and cauliflower, citrus, beans, peas, lentils, avocado, seeds and nuts, beets. Omega-3 Fish oil is rich in omega-3 fatty acids, a major building block in optimal brain chemistry. Americans get adequate amounts of omega-6 fatty acids, we often come up short in omega-3s. Without enough omega-3s, "you tend to not transmit nerve signals properly, "When your brain isn't running properly, you can feel depressed or anxious. VITAMIN D Vitamin D helps combat anxiety and depression. A 2008 study of 441 overweight and obese men and women in Norway found that those given 20,000 and 40,000 IUs per week of vitamin D supplements had significantly less depression symptoms after one year than those in a placebo group. B-COMPLEX VITAMINS Mild depression is an imbalance of brain neurotransmitters-natural chemicals that can act as mood enhancers by helping transmit signals between brain cells. A 2004 Danish study of 140 people found that those who were clinically depressed had low levels of vitamin B6 in their blood. If upping serotonin levels through B6 and B3 doesn't help, turning to vitamin B12 plus folic acid, A 2002 Dutch study of nearly 4,000 elderly people backs up this suggestion: Researchers found that many of those who had depression symptoms also had vitamin B12 deficiency. Richest among all the vitamin B complex foods are milk, yeast, liver, whole-grain cereals, nuts, eggs, yogurt, fruits, meats and leafy vegetables. B-Complex sources: Sublingual B-12 Pork, berries, legumes, lean meats. Nuts, soy milk (Vitamin B1) Eggs, dark green vegetables, fish, grains, lean meat, mushrooms (B2) Sunflower seeds, tuna, poultry, potato, cottage cheese, liver (B3) Organ meats, avocados, broccoli, mushrooms(B5) Green beans, whole grains, spinach, fish, bananas(B6) Soy products, egg yolks, fish, organ meats, cheese, sweet potatoes(B7) Green leafy vegetables, citrus juice, legumes, tofu, tomato juice (B9) Milk, fish, fortified breakfast cereal, eggs, shellfish (B12)   For more from Chef Wendell including the “Eat Right Now” books and info on how to book Chef Wendell to speak to your group go to http://www.chefwendell.com. To connect with the Live Right Now Podcast “like” our Facebook page or email us at LiveRightNowRadio@gmail.com.   The Live Right Now theme music is “future soundtrack II” by Adam Henry Garcia from the Free Music Archive licensed under CC BY-NC-SA 4.0  

Host: Matt Birnholz, MD Guest: Carol Lippa, MD Understandings of the origins and mechanisms of Alzheimer's disease are evolving constantly, opening doors to improved targets for therapeutic research. But at a time when disease-modifying therapies for advanced Alzheimer's aren't yet available, the need for early detection becomes critically important to help protect quality of life for patients. Host Dr. Matt Birnholz welcomes Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine. Dr. Lippa is a member of the Board of Directors for the Alzheimer's Association and Chair of the Delaware Valley Chapter's Medical & Scientific Committee. Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD Guest: Carol Lippa, MD Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine, member of the Board of Directors for the Alzheimer's Association, and Chair of the Delaware Valley Chapter's Medical & Scientific Committee, reveals the biological, social, and stigma-based ways in which Alzheimer's remains the most prominently "hidden" disease in America. Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD Guest: Carol Lippa, MD Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine, member of the Board of Directors for the Alzheimer's Association, and Chair of the Delaware Valley Chapter's Medical & Scientific Committee, reveals the biological, social, and stigma-based ways in which Alzheimer's remains the most prominently "hidden" disease in America. Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD Guest: Carol Lippa, MD Understandings of the origins and mechanisms of Alzheimer's disease are evolving constantly, opening doors to improved targets for therapeutic research. But at a time when disease-modifying therapies for advanced Alzheimer's aren't yet available, the need for early detection becomes critically important to help protect quality of life for patients. Host Dr. Matt Birnholz welcomes Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine. Dr. Lippa is a member of the Board of Directors for the Alzheimer's Association and Chair of the Delaware Valley Chapter's Medical & Scientific Committee. Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD Guest: Carol Lippa, MD Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine, member of the Board of Directors for the Alzheimer's Association, and Chair of the Delaware Valley Chapter's Medical & Scientific Committee, reveals the biological, social, and stigma-based ways in which Alzheimer's remains the most prominently "hidden" disease in America. Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD Guest: Carol Lippa, MD Understandings of the origins and mechanisms of Alzheimer's disease are evolving constantly, opening doors to improved targets for therapeutic research. But at a time when disease-modifying therapies for advanced Alzheimer's aren't yet available, the need for early detection becomes critically important to help protect quality of life for patients. Host Dr. Matt Birnholz welcomes Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine. Dr. Lippa is a member of the Board of Directors for the Alzheimer's Association and Chair of the Delaware Valley Chapter's Medical & Scientific Committee. Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD Guest: Carol Lippa, MD Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine, member of the Board of Directors for the Alzheimer's Association, and Chair of the Delaware Valley Chapter’s Medical & Scientific Committee, reveals the biological, social, and stigma-based ways in which Alzheimer's remains the most prominently "hidden" disease in America. Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD Guest: Carol Lippa, MD Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine, member of the Board of Directors for the Alzheimer's Association, and Chair of the Delaware Valley Chapter’s Medical & Scientific Committee, reveals the biological, social, and stigma-based ways in which Alzheimer's remains the most prominently "hidden" disease in America. Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD Guest: Carol Lippa, MD Understandings of the origins and mechanisms of Alzheimer's disease are evolving constantly, opening doors to improved targets for therapeutic research. But at a time when disease-modifying therapies for advanced Alzheimer's aren't yet available, the need for early detection becomes critically important to help protect quality of life for patients. Host Dr. Matt Birnholz welcomes Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine. Dr. Lippa is a member of the Board of Directors for the Alzheimer's Association and Chair of the Delaware Valley Chapter’s Medical & Scientific Committee. Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection

Host: Matt Birnholz, MD Guest: Carol Lippa, MD Understandings of the origins and mechanisms of Alzheimer's disease are evolving constantly, opening doors to improved targets for therapeutic research. But at a time when disease-modifying therapies for advanced Alzheimer's aren't yet available, the need for early detection becomes critically important to help protect quality of life for patients. Host Dr. Matt Birnholz welcomes Dr. Carol Lippa, Professor of Neurology & Director of the Memory Disorders Program at Drexel University College of Medicine. Dr. Lippa is a member of the Board of Directors for the Alzheimer's Association and Chair of the Delaware Valley Chapter’s Medical & Scientific Committee. Uncover the truth about Alzheimer's in the non-certified educational series, Alzheimer's Disease: Towards Earlier Detection